Literature DB >> 15150326

Characterization of a haemolytic phospholipase A(2) activity in clinical isolates of Campylobacter concisus.

Taghrid S Istivan1, Peter J Coloe1, Benjamin N Fry1, Peter Ward1, Stuart C Smith1.   

Abstract

A membrane-bound, haemolytic phospholipase A(2) (PLA(2)) activity was detected in clinical strains of Campylobacter concisus isolated from children with gastroenteritis. The clinical strains were assigned into two molecular groups (genomospecies) based on PCR amplification of their 23S rDNA. This calcium-dependent, heat-stable, haemolytic PLA(2) activity was detected in strains from both genomospecies. A crude haemolysin extract (CHE) was initially prepared from cellular outer-membrane proteins of these isolates and was further fractionated by ultrafiltration. The haemolytic activity of the extracted fraction (R30) was retained by ultrafiltration using a 30 kDa molecular mass cut-off filter, and was designated haemolysin extract (HE). Both CHE and HE had PLA(2) activity and caused stable vacuolating and cytolytic effects on Chinese hamster ovary cells in tissue culture. Primers for the conserved region of pldA gene (phospholipase A gene) from Campylobacter coli amplified a gene region of 460 bp in all tested isolates, confirming the presence of a homologous PLA gene sequence in C. concisus. The detection of haemolytic PLA(2) activity in C. concisus indicates the presence of a potential virulence factor in this species and supports the hypothesis that C. concisus is a possible opportunistic pathogen.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15150326     DOI: 10.1099/jmm.0.45554-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  21 in total

Review 1.  IBD-what role do Proteobacteria play?

Authors:  Indrani Mukhopadhya; Richard Hansen; Emad M El-Omar; Georgina L Hold
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

2.  Delineation of Campylobacter concisus genomospecies by amplified fragment length polymorphism analysis and correlation of results with clinical data.

Authors:  Rune Aabenhus; Stephen L W On; Berit L Siemer; Henrik Permin; Leif P Andersen
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Breast-fed and bottle-fed infant rhesus macaques develop distinct gut microbiotas and immune systems.

Authors:  Amir Ardeshir; Nicole R Narayan; Gema Méndez-Lagares; Ding Lu; Marcus Rauch; Yong Huang; Koen K A Van Rompay; Susan V Lynch; Dennis J Hartigan-O'Connor
Journal:  Sci Transl Med       Date:  2014-09-03       Impact factor: 17.956

Review 4.  The clinical importance of emerging Campylobacter species.

Authors:  Si Ming Man
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-25       Impact factor: 46.802

Review 5.  The role of bacteria and pattern-recognition receptors in Crohn's disease.

Authors:  Si Ming Man; Nadeem O Kaakoush; Hazel M Mitchell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02-08       Impact factor: 46.802

6.  Detection and isolation of Campylobacter species other than C. jejuni from children with Crohn's disease.

Authors:  Li Zhang; Si Ming Man; Andrew S Day; Steven T Leach; Daniel A Lemberg; Shoma Dutt; Michael Stormon; Anthony Otley; Edward V O'Loughlin; Annabel Magoffin; Patrick H Y Ng; Hazel Mitchell
Journal:  J Clin Microbiol       Date:  2008-12-03       Impact factor: 5.948

7.  First attempt to produce experimental Campylobacter concisus infection in mice.

Authors:  Rune Aabenhus; Unne Stenram; Leif Percival Andersen; Henrik Permin; Asa Ljungh
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

8.  A bioactive peptide analogue for myxoma virus protein with a targeted cytotoxicity for human skin cancer in vitro.

Authors:  Nahlah M Almansour; Elena Pirogova; Peter J Coloe; Irena Cosic; Taghrid S Istivan
Journal:  J Biomed Sci       Date:  2012-07-17       Impact factor: 8.410

9.  Prevalence of Campylobacter species in adult Crohn's disease and the preferential colonization sites of Campylobacter species in the human intestine.

Authors:  Vikneswari Mahendran; Stephen M Riordan; Michael C Grimm; Thi Anh Tuyet Tran; Joelene Major; Nadeem O Kaakoush; Hazel Mitchell; Li Zhang
Journal:  PLoS One       Date:  2011-09-23       Impact factor: 3.240

Review 10.  Campylobacter concisus - A new player in intestinal disease.

Authors:  Nadeem Omar Kaakoush; Hazel Marjory Mitchell
Journal:  Front Cell Infect Microbiol       Date:  2012-02-03       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.